Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
AAM Applauds HHS For Acknowledging Brand-Driven Cost Increases
Association Recommends Policy Solutions To Congress As Proposals To Lower Prices Unveiled
Sep 14 2021
•
By
Akriti Seth
The AAM has welcomed the HHS’s plans to lower drug prices • Source: Alamy
More from Policy & Regulation
More from Generics Bulletin